Passive antibody therapy in the treatment of COVID-19 - Minh Tran, CCP
Passive antibody therapy in the treatment of COVID-19 - Minh Tran, CCP

Passive antibody therapy in the treatment of COVID-19 - Minh Tran, CCP

  • Faculty: Program director Joseph Basha, CCP
  • Date: May 26th, 2020 11:00 am
  • CEU’s: 0.84 CEUs
  • Price: $12.6
  • Category 1 SDCE CEU
Buy Course
Course Rating:
(9 Reviews)

Latest Reviews

View All

Course description

Minh Tran, CCP and Joe Basha, CCP discuss the use of passive antibody therapy, also referred to as convalescent plasma. 

An old therapy making a resurgence in the treatment of COVID-19. 
0:00 Passive antibody therapy in the treatment of COVID-19 
1:16 Convalescent Plasma Therapy Covid-19 
5:55 Convalescent Whole Blood, Plasma and Serum in the Prophylaxis of Measles 

Understanding Passive Antibody Therapy in the Fight Against COVID-19

In the unceasing struggle against COVID-19, a plethora of treatments, vaccines, and therapeutic strategies have been developed and scrutinized. Amidst these, one of the most intriguing yet often misunderstood options is Passive Antibody Therapy, specifically through the use of convalescent plasma. Our latest video, featuring insights from Dr. Richard Migliore, the Chief Medical Officer (CMO) of United Health, aims to shed light on this fascinating subject, demystifying the science and potential of passive antibody therapy for COVID-19 treatment.

What Is Passive Antibody Therapy?

Before delving into the nitty-gritty, it's essential to understand what Passive Antibody Therapy actually is. In essence, it involves transferring antibodies from a recovered COVID-19 patient to a currently infected individual. These antibodies, part of the immune system's arsenal, can potentially aid in fighting off the virus more effectively. Passive antibody therapy has been used in the past to treat various diseases like measles, rabies, and even during the H1N1 flu pandemic.

Convalescent Plasma: A Ray of Hope

One of the primary methods of administering passive antibody therapy is through convalescent plasma. This plasma is extracted from individuals who have recovered from COVID-19 and is rich in antibodies. Dr. Migliore provides an in-depth look into how convalescent plasma can be a valuable resource in treating severe and critical COVID-19 cases. The therapy is not without its challenges, such as the variability in antibody concentration and the need for rigorous screening, but the potential benefits in reducing severity and mortality rates are promising.

The Science Behind It

What makes this video particularly enlightening is the science it unpacks. It doesn't merely assert the efficacy of convalescent plasma; it explains why and how it can work. From the role of antibodies in neutralizing the virus to the mechanics of plasma extraction and transfusion, the video covers it all. These scientific perspectives add a layer of credibility and understanding that is often missing in mainstream discussions about COVID-19 treatments.

Current Status and Future Prospects

Of course, no treatment option is a silver bullet, and passive antibody therapy is no exception. The video delves into the current limitations, such as the need for more extensive clinical trials and the potential risk factors. However, it also discusses ongoing research and future prospects, including the development of more refined antibody-based drugs that can offer targeted treatment with fewer side effects.

Why This Video Is a Must-Watch

1. Expert Insights: Dr. Migliore, with his extensive experience in healthcare, offers invaluable expert opinions and clarifications.
2. Comprehensive Coverage: The video doesn’t just skim the surface. It dives deep into the science, the challenges, and the future of passive antibody therapy.
3. Timely and Relevant: As we continue to grapple with the pandemic, understanding all available treatment options is crucial for both healthcare providers and the general public.

4. Accessible Science: The video makes complex scientific concepts accessible to the layperson, without compromising on depth or accuracy.

5. A Balanced View: While advocating for the potential benefits of passive antibody therapy, the video also critically examines its limitations, offering a balanced and well-rounded perspective.

In summary, our latest video on Passive Antibody Therapy in the treatment of COVID-19 is a comprehensive guide that anyone—be it healthcare professionals, patients, or individuals interested in medical science—would find extremely beneficial. As we navigate through these challenging times, knowledge is our most potent weapon. This video equips you with the scientific understanding needed to appreciate the complexities and possibilities in treating COVID-19, making it an essential watch for all.

#perfusion #covid-19 #antibodytherapy 
Register and watch for free @ 
IV Dosage and Rate Calculator - 

Meet Your Instructor

Program director Joseph Basha, CCP

Program director Joseph Basha, CCP

Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference

Read Full Bio